Infliximab or biosimilars in sarcoidosis; to switch or not to switch?

Main Article Content

M. Veltkamp
M. Drent
R. P. Baughman

Keywords

Abstract

Not available
a

Downloads

Download data is not yet available.
Abstract 318 | PDF Downloads 140